IMPORTANT: Investment involves risk, including the loss of principal. Investors are advised to consider their own investment objectives and circumstances in determining the suitability of an investment in this Fund. An investment in this Fund may not be suitable for everyone. If you are in any doubt, you should consult your stockbroker, bank manager, solicitor, accountant or other financial adviser for independent financial advice. Investors should refer to the Fund prospectus for further details, including the product features and risk factors. Investors should not base on this marketing material alone to make investment decisions. Investors should note:
• The Fund may  invest in India Access Products ("IAPs") being derivative instruments linked to Indian Securities issued by third parties. An IAP represents only an obligation of the IAP Issuer to provide the economic performance of the underlying Indian Security, and is a financial derivative subject to counterparty risk associated with the IAP issuer. The Fund may suffer losses potentially equal to the full value of the IAPs issued by the IAP issuer if such IAP issuer fails to perform its obligations under the IAP.
• The Fund is subject to concentration risk as a result of investing into a single country.
• Generally, investments in emerging markets are subject to a greater risk of loss than investments in a developed market. This is due to, among other things, greater market volatility, lower trading volume, political and economic instability, lack of regulation, greater risk of market shutdown and more governmental limitations on foreign investment policy than typical found in developed markets.
• Prices on the SGX are based on secondary market trading factors and may deviate significantly from the net asset value of the Fund.